Upgrade to SI Premium - Free Trial

BriaCell adds Memorial Sloan Kettering to Phase 3 breast cancer trial

September 8, 2026 7:30 AM
BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXL; TSX: BCT) announced that Memorial Sloan Kettering Cancer Center (MSK) has joined its ongoing ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

FDA